inTEST Updates Full Year 2024 Guidance Due To Alfamation Acquisition; Boosts 2024 Revenue Outlook From $125M-$130M To $145M-$155M; Est $125.795M
The acquisition is expected to be dilutive to earnings per diluted share in 2024, but accretive to non-GAAP adjusted EPS due to the anticipated impacts associated with the amortization of intangible assets. Given the timing of the acquisition, the impact to first quarter 2024 results from operations are expected to be nominal.